Workshop. information

Size: px

Start display at page:

Download "Workshop. information"

Susanna Price
6 years ago
Views:

1 Workshop information Wonderful workshop, it s one that always attracts interesting speakers. I strongly recommend it to every HIV/AIDS clinician & researcher in Africa. This is the African CROI. 1

Speakers feedback The INTEREST workshop was one of the best run meetings I have ever attended.

I also enjoyed the less formal hallway discussions with attendees as such interactions rarely occur at the larger international meetings.

Steven Deeks University of California, San Francisco The INTEREST meetings, since they started in Kampala, have given young researchers and their mentors the much needed opportunities to present

Elly Katabira Makarere University College of Health Sciences in Kampala, Uganda Th e 7 th INTEREST Workshop in Dakar, Senegal, May 2013, provided a forum for the high-level exchange of scientific

Timothy Mastro FHI 360, USA The INTEREST workshop is an unique platform for African clinicians and scientists to show case their work and share both the challenges they face and the solutions they

2 Speakers feedback The INTEREST workshop was one of the best run meetings I have ever attended. Having a chance to share our work in San Francisco with a packed and attentive audience of engaged clinicians an d investigators in Africa made the trip worthwhile, and I would certainly do it again. I also enjoyed the less formal hallway discussions with attendees as such interactions rarely occur at the larger international meetings. I have encouraged my US-based colleagues to attend future meetings if possible. Steven Deeks University of California, San Francisco The INTEREST meetings, since they started in Kampala, have given young researchers and their mentors the much needed opportunities to present their work and also meet other researchers from other countries. This kind of interactions has resulted into new collaborations as new talents of young researchers are discovered. Elly Katabira Makarere University College of Health Sciences in Kampala, Uganda Th e 7 th INTEREST Workshop in Dakar, Senegal, May 2013, provided a forum for the high-level exchange of scientific advances that will improve the prevention of HIV infection and the care of people living with HIV in Africa. Timothy Mastro FHI 360, USA The INTEREST workshop is an unique platform for African clinicians and scientists to show case their work and share both the challenges they face and the solutions they develop. It is a critical element of strengthening the African scientific community and forging new collaborations to advance the African medical research agenda. This meeting affords young investigators opportunity to share the stage with experience senior investigators in a setting which comfortably facilitates an active and open interaction. Sponsors are contributing to the development and enhancement of scientific rigor in a setting of desperate need. Personally, as an invited speaker, I have benefitted greatly and learned a great deal about the evolving research landscape of the African community through my participation. I hope to have the privilege of participating in this dynamic and enriching meeting in future. Merlin Robb US Military HIV Research Program, USA INTEREST est une rencontre scientifique qui regroupe des experts impliqués dans différentes disciplines de recherche sur le VIH. Elle permet de créer un espace de discussion sur la manière de traduire et d appliquer les découvertes récentes sur le VIH en nouvelles stratégies d intervention mieux adapter aux pays à ressources limitées. C est un cadre d échange d expériences et promotion de collaboration à travers une plate-forme pour la recherche sur le VIH, spécialement pour les jeunes chercheurs par le renforcement de capacité et de transfert d expériences multidisciplinaires grâce à l atmosphère collégiale de la rencontre. INTEREST met l accent sur les questions présentant un intérêt particulier pour le continent Africain. Coumba Touré Kane Laboratoire de Bacteriologie-Virologie CHU Le Dantec, Dakar University, Senegal 2

3 Introduction 8 th INTEREST Workshop The INTEREST Workshop initiative was launched in 2007 and spearheaded by Professors Joep M.A. Lange (Amsterdam Institute for Global Health and Development (AIGHD), Academic Medical Center, department of Global Health/University of Amsterdam) and Charles A.B. Boucher (Erasmus Medical Center Rotterdam, University of Rotterdam). Together with a prominent group of international experts in the fi eld of HIV/AIDS, a focused annual international meeting in Africa has been developed. During these meetings, experts in the fi eld of HIV prevention and treatment share their knowledge and views on a variety of HIV-related topics. The workshop focuses on issues of particular relevance for the African continent and gives the opportunity for young researchers to present their data. The workshop size and atmosphere facilitates discussion and interaction between the participants. Seven successful meetings have been convened since INTEREST s inception, the fi rst being held in Uganda, followed by Senegal, Zambia, Mozambique, Tanzania, Kenya, and, again in 2013, Senegal. The 8 th INTEREST Workshop will take place in Lusaka, Zambia, from May 5 -May 9 (mid-day), The format of the meeting is a two and a half day program consisting of plenary sessions on HIV prevention and treatment with presentations by renowned invited speakers, abstract-driven presentations, round table discussions and poster sessions. Additional time will be allocated to questions & answers and discussion in order to foster an intimate interactive workshop. This year s workshop will start with a pre-workshop with two parallel workshops from till hrs on May 5. The workshops, including meet-the-experts will be organized for people with a special interest in: 1 Pediatrics and PMTCT (Option B+) 2 Implementation science Participants can register separately for the pre-workshop and the 8 th INTEREST Workshop. For participants from Zambia and Zimbabwe there will be a special, reduced, registration fee. Unlike previous years, the fi rst session of the Workshop on HIV drug resistance (AIGHD/PASER) will start on Tuesday May 6 in the morning, followed by two premium satellite symposia, organized by respectively AbbVie, and Janssen Pharmaceutical Companies of Johnson & Johnson. We are happy to announce our partnership with the Southern African HIV Clinicians Society and RESAPSI (Réseau Africain des praticiens assurant la prise en charge médicale des personnes vivant avec le VIH). We hope you will join us in this important educational opportunity. On behalf of the Organizing Committee, Joep Lange, MD, PhD AMC, University of Amsterdam / Amsterdam Institute for Global Health and Development (AIGHD) Charles Boucher, MD, PhD Erasmus Medical Center, Rotterdam, the Netherlands 3

4 Participants feedback Scientific Committee The workshop is well organized, the presentations are so nicely prepared and are highly updating in terms of recent discoveries and evidence based scientifi c fi ndings on HIV epidemics and treatments worldwide and sub Saharan Africa. This is the African CROI. I do suggest that the INTEREST Workshop should be an ongoing process and this program should include the participants from outside the African continent. Very good presentations that are relevant to my routine work. Wonderful workshop, it s one that always attracts interesting speakers. I strongly recommend it to every HIV/AIDS clinician & researcher in Africa. A State-of-the-ART Workshop. The key note lectures are worth to be presented to the participants in print/copy because these are remarkable points that should be passed on. Hope to participate again in future. Impressive quality of presentations from the younger African clinicians and scientists. Linda-Gail Bekker, MBChB, FCP, PhD Desmond Tutu HIV Foundation, University of Cape Town, South Africa Namwinga Chintu, MD, MMed (Ped) Centre for Infectious Disease Research (CIDRZ), Zambia Bob Colebunders, MD, PhD Institute of Tropical Medicine, University of Antwerp, Belgium Serge Eholié, MD, PhD CHU de Treichville, University of Abidjan, Ivory Coast Guido Ferrari, MD Duke University Medical Center, USA Catherine Hankins BA, MD, MSc, CCFP, FRCPC AIGHD, the Netherlands / London school of Hygiene and Tropical Medicine, UK Grace John-Stewart, MD, PhD University of Washington, USA Andrew Kambugu, MBChB, MMed Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda, Peter Kilmarx, MD, FACP, FIDSA CDC Centers for Disease Control and Prevention, Zimbabwe Nagalingeswaran Kumarasamy, MD YRG Centre for AIDS Research and Education, India Catharine Kyobutungi, PhD African Population and Health Research (APHRC), Kenya Kishor Mandaliya, MBChB FRCPath International Centre for Reproductive Health (ICRH) and Pathcare labs Mombasa, Kenya Fred Mhalu, MBChB, FRCPath, DrMed Muhimbili University of Health and Allied Sciences, Tanzania Mauro Schechter, MD, PhD Federal University Rio de Janeiro, Brazil Robert Schooley, MD University of California, San Diego, USA Coumba Touré Kane, PharmD, PhD Laboratoire de Bacteriologie-Virologie CHU Le Dantec, Dakar University, Senegal Dawit Wolday Medical Biotech Laboratories (MBL), Addis Ababa, College of Health Sciences-Mekelle University, Mekelle, Ethiopia Robin Wood, MBChB, BMBCh Desmond Tutu HIV Foundation, University of Cape Town, South Africa Debrework Zewdie, PhD The World Bank, USA 4

Organizing Commitee Charles Boucher, MD, PhD

Netherlands Pierre-Marie Girard, MD, PhD

Marie Curie, Paris, France James Hakim, MD

Zimbabwe College of Health Sciences Harare,

University College of Health Sciences in

Amsterdam, Amsterdam Institute for Global

Mastro, MD, FACP, DTM&H FHI 360, University

Albert Mwango, BScHB, MBChB, MPH Ministry of

Health Research Unit (RHRU), University of

Africa Anna Laura Ross, PhD National Agency

5 Organizing Commitee Charles Boucher, MD, PhD Erasmus Medical Center, Rotterdam, the Netherlands Pierre-Marie Girard, MD, PhD Hôpital Saint-Antoine,Université Pierre et Marie Curie, Paris, France James Hakim, MD Department of Medicine, University of Zimbabwe College of Health Sciences Harare, Zimbabwe Elly Katabira, MD, FRCP Makarere University College of Health Sciences in Kampala, Uganda Richard Koup, MD Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA Joep Lange, MD, PhD Academic Medical Center (AMC), University of Amsterdam, Amsterdam Institute for Global Health and Development, the Netherlands Chewe Luo, MD, PhD UNICEF, USA and University Teaching Hospital, Zambia Timothy Mastro, MD, FACP, DTM&H FHI 360, University of North Carolina at Chapel Hill, NC, USA Albert Mwango, BScHB, MBChB, MPH Ministry of Health, Zambia Helen Rees, MD Reproductive Health Research Unit (RHRU), University of the Witwatersrand, Johannesburg, South Africa Anna Laura Ross, PhD National Agency for Aids Research (ANRS), Paris, France Papa Salif Sow, MD, MS Cheikh Anta Diop University, Dakar, Senegal / Bill & Melinda Gates Foundation, Gates Foundation, USA Kenly Sikwese African Community Advisory Board (AFROCAB), Zambia François Venter, MD RHRU, University of the Witwatersrand, South Africa 5

6 Preliminary Program Layout 5 May - Pre-workshop day h 2 parallel workshops h IAS symposium 6 May - Pre-opening day 9.00 h Workshop h Premium satellite symposium Janssen 14.00h Premium satellite symposium AbbVie h Opening session of the workshop h Welcome reception 7 May - Day h Plenary sessions h Premium satellite symposium slot h Lunch and poster viewing h Round table, oral abstracts, symposium h Premium satellite symposium slot h Drinks and poster viewing 8 May - Day h Plenary sessions h Premium satellite symposium slot h Lunch and poster viewing h Round table, oral abstracts, symposium h Premium satellite symposium slot h Workshop dinner 9 May - Day h Plenary sessions h Rapporteur session h Closure of the workshop For program and registration : or 6

Meeting Objectives To function as a platform to discuss how recent insights in HIV may translate to new intervention strategies for areas with limited resources To gather experts involved in HIV from

7 Meeting Objectives To function as a platform to discuss how recent insights in HIV may translate to new intervention strategies for areas with limited resources To gather experts involved in HIV from different disciplines in an interactive workshop setting To provide a platform for presentation and discussion of the latest developments in the fi eld To translate new data to treatment guidelines To stimulate discussion and consensus on best practice To give young researchers a platform. Target Audience The target audience of the INTEREST Workshop consists of clinicians involved in HIV treatment and care, researchers, medical and PhD students. Meeting Statistics Number and professional background of participants Total number Clinical Doctor 63% 44% 50% Researcher 15% 33% 21% Community advocate 0% 2% 4% Industry representative 4% 7% 2% Other 18% 14% 16% 7

It has been called the African CROI. It makes my calendar before CROI (but don t tell anyone!). Organizers Attending the INTEREST workshop is memorable from several points of view.

informed audience. All of this takes place in the plenary setting with ample time provided for engaged interchanges between audience members and presenters of all levels.

8 It has been called the African CROI. It makes my calendar before CROI (but don t tell anyone!). Organizers Attending the INTEREST workshop is memorable from several points of view. International and African plenary speakers present the latest state of the art HIV science while up and coming African new investigators have an opportunity to present their findings to a highly informed audience. All of this takes place in the plenary setting with ample time provided for engaged interchanges between audience members and presenters of all levels. Exchanges around posters presented in the health break/tea/coffee area are animated, providing an opportunity that is less daunting for some INTEREST workshop participants than the plenary hall to make contact with individual presenters and share their experiences in similar domains. The skills of scientific presentation, responding to queries and challenges, and translation of scientific knowledge across disciplines are all modelled by senior participants who encourage young researchers to participate actively. Young enthusiastic scientists get new ideas for directions they could take their research in and, often for the first time, feel part of a community of African researchers. Serious consideration should be given to webcasting or, at a minimum, video recording the conference for ease of sharing emerging science across Africa. As well, it could play an important role in facilitating cross-continent linkages between research teams and individual researchers. Catherine Hankins Amsterdam Institute for Global Health and Development (AIGHD), London School of Hygiene and Tropical Medicine Partners Contacts Academic Medical Center, University of Amsterdam / Amsterdam Institute for Global Health and Development (AIGHD) Pietersbergweg 17, 1105 BM Amsterdam The Netherlands Virology Education Biltstraat 106, 3572 BJ Utrecht The Netherlands Program and sponsoring Jacqueline van Tongeren T +31 (0) M +31 (0) E j.vantongeren@aighd.org Senior Event Manager (Logistics) Jo-Els van der Woude T: +31 (0) M +31 (0) E jo-els@vironet.com Managing Director Virology Education Alice Posthumus T +31 (0) M +31 (0) E alice.posthumus-plantinga@vironet.com For program and registration : or

SPONSORSHIP REQUEST 2017 INTEREST HIV TREATMENT, PATHOGENESIS AND PREVENTION RESEARCH IN RESOURCE-LIMITED SETTINGS.

SPONSORSHIP REQUEST 2017 INTEREST HIV TREATMENT, PATHOGENESIS AND PREVENTION RESEARCH IN RESOURCE-LIMITED SETTINGS. 11 TH INTERNATIONAL WORKSHOP ON HIV TREATMENT, PATHOGENESIS AND PREVENTION RESEARCH IN RESOURCE-LIMITED SETTINGS INTEREST LILONGWE, MALAWI MAY 16-19 2017 SPONSORSHIP REQUEST 2017 www.virology-education.com